Column Group LLC
Follow13F filer, CIK 1833486, San Francisco, CA
Column Group LLC reported $44,225,589 across 5 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-005219
- Period
- 2025-03-31
- Reported value
- $44.2M
- Holdings
- 5
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| Surrozen, Inc.added | +689,685 | $8.04M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q1 2025
Share positions as resolved from 13F-HR 0000950123-25-005219, largest first. % of portfolio is the value over $44,225,589, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ORICORIC PHARMACEUTICALS INC | 3,540,777 | $19.8M | 44.67% | 0 | Timeline | ||
| Surrozen, Inc.Surrozen, Inc. | 1,499,773 | $17.5M | 39.54% | +689,685 | |||
| TNYATENAYA THERAPEUTICS INC | 9,400,290 | $5.36M | 12.12% | 0 | Timeline | ||
| RAPT THERAPEUTICS INCRAPT THERAPEUTICS INC | 1,328,613 | $1.62M | 3.67% | 0 | |||
| RVMDREVOLUTION MEDICINES INC | 46 | $1.63K | <0.01% | 0 | Timeline |
How Q1 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-25-005219 | base | 2025-05-14 | acceptance time not in the bulk data set |